vs
Side-by-side financial comparison of TWIN DISC INC (TWIN) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $90.2M, roughly 1.0× TWIN DISC INC). Vericel Corp runs the higher net margin — 25.0% vs 24.8%, a 0.2% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 0.3%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $1.2M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 10.3%).
Twin Disc, Inc. designs, manufactures, and distributes power transmission equipment for a wide range of applications, including marine, off-road vehicle, and industrial. The company was founded in 1918 to manufacture clutches for farm tractors. It is now a worldwide company with subsidiaries or sales offices in Asia, Europe, North America, Oceania, and South America.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
TWIN vs VCEL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.2M | $92.9M |
| Net Profit | $22.4M | $23.2M |
| Gross Margin | 24.8% | 78.7% |
| Operating Margin | 2.3% | 24.1% |
| Net Margin | 24.8% | 25.0% |
| Revenue YoY | 0.3% | 23.3% |
| Net Profit YoY | 2334.3% | 17.3% |
| EPS (diluted) | $1.55 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.2M | $92.9M | ||
| Q3 25 | $80.0M | $67.5M | ||
| Q2 25 | $96.7M | $63.2M | ||
| Q1 25 | $81.2M | $52.6M | ||
| Q4 24 | $89.9M | $75.4M | ||
| Q3 24 | $72.9M | $57.9M | ||
| Q2 24 | $84.4M | $52.7M | ||
| Q1 24 | $74.2M | $51.3M |
| Q4 25 | $22.4M | $23.2M | ||
| Q3 25 | $-518.0K | $5.1M | ||
| Q2 25 | $1.4M | $-553.0K | ||
| Q1 25 | $-1.5M | $-11.2M | ||
| Q4 24 | $919.0K | $19.8M | ||
| Q3 24 | $-2.8M | $-901.0K | ||
| Q2 24 | $7.4M | $-4.7M | ||
| Q1 24 | $3.8M | $-3.9M |
| Q4 25 | 24.8% | 78.7% | ||
| Q3 25 | 28.7% | 73.5% | ||
| Q2 25 | 31.0% | 73.7% | ||
| Q1 25 | 26.7% | 69.0% | ||
| Q4 24 | 24.1% | 77.6% | ||
| Q3 24 | 26.5% | 71.9% | ||
| Q2 24 | 29.7% | 69.5% | ||
| Q1 24 | 28.2% | 68.9% |
| Q4 25 | 2.3% | 24.1% | ||
| Q3 25 | 2.8% | 5.1% | ||
| Q2 25 | 5.5% | -3.2% | ||
| Q1 25 | 2.4% | -24.3% | ||
| Q4 24 | 3.1% | 24.5% | ||
| Q3 24 | -0.2% | -4.3% | ||
| Q2 24 | 5.6% | -11.5% | ||
| Q1 24 | 4.9% | -10.7% |
| Q4 25 | 24.8% | 25.0% | ||
| Q3 25 | -0.6% | 7.5% | ||
| Q2 25 | 1.5% | -0.9% | ||
| Q1 25 | -1.8% | -21.4% | ||
| Q4 24 | 1.0% | 26.3% | ||
| Q3 24 | -3.8% | -1.6% | ||
| Q2 24 | 8.8% | -8.9% | ||
| Q1 24 | 5.2% | -7.5% |
| Q4 25 | $1.55 | $0.46 | ||
| Q3 25 | $-0.04 | $0.10 | ||
| Q2 25 | $0.10 | $-0.01 | ||
| Q1 25 | $-0.11 | $-0.23 | ||
| Q4 24 | $0.07 | $0.40 | ||
| Q3 24 | $-0.20 | $-0.02 | ||
| Q2 24 | $0.54 | $-0.10 | ||
| Q1 24 | $0.27 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | $44.5M | — |
| Stockholders' EquityBook value | $184.5M | $354.6M |
| Total Assets | $384.0M | $488.0M |
| Debt / EquityLower = less leverage | 0.24× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
| Q4 25 | $44.5M | — | ||
| Q3 25 | $43.7M | — | ||
| Q2 25 | $31.4M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $24.9M | — | ||
| Q3 24 | $29.8M | — | ||
| Q2 24 | $25.8M | — | ||
| Q1 24 | $17.0M | — |
| Q4 25 | $184.5M | $354.6M | ||
| Q3 25 | $160.3M | $321.9M | ||
| Q2 25 | $164.0M | $306.8M | ||
| Q1 25 | $149.5M | $295.5M | ||
| Q4 24 | $147.0M | $292.0M | ||
| Q3 24 | $157.5M | $257.5M | ||
| Q2 24 | $154.7M | $243.0M | ||
| Q1 24 | $146.3M | $233.9M |
| Q4 25 | $384.0M | $488.0M | ||
| Q3 25 | $363.5M | $453.3M | ||
| Q2 25 | $355.6M | $435.6M | ||
| Q1 25 | $332.9M | $424.6M | ||
| Q4 24 | $307.4M | $432.7M | ||
| Q3 24 | $323.5M | $390.4M | ||
| Q2 24 | $312.1M | $376.8M | ||
| Q1 24 | $288.8M | $356.7M |
| Q4 25 | 0.24× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.17× | — | ||
| Q1 24 | 0.12× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.6M | $15.0M |
| Free Cash FlowOCF − Capex | $1.2M | $12.8M |
| FCF MarginFCF / Revenue | 1.4% | 13.8% |
| Capex IntensityCapex / Revenue | 3.7% | 2.4% |
| Cash ConversionOCF / Net Profit | 0.20× | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-70.0K | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.6M | $15.0M | ||
| Q3 25 | $-7.5M | $22.1M | ||
| Q2 25 | $16.4M | $8.2M | ||
| Q1 25 | $3.2M | $6.6M | ||
| Q4 24 | $8.7M | $22.2M | ||
| Q3 24 | $-4.3M | $10.2M | ||
| Q2 24 | $11.4M | $18.5M | ||
| Q1 24 | $6.2M | $7.2M |
| Q4 25 | $1.2M | $12.8M | ||
| Q3 25 | $-11.0M | $19.5M | ||
| Q2 25 | $8.7M | $81.0K | ||
| Q1 25 | $906.0K | $-7.6M | ||
| Q4 24 | $5.9M | $8.5M | ||
| Q3 24 | $-6.7M | $-9.2M | ||
| Q2 24 | $10.3M | $1.8M | ||
| Q1 24 | $4.0M | $-6.8M |
| Q4 25 | 1.4% | 13.8% | ||
| Q3 25 | -13.7% | 28.8% | ||
| Q2 25 | 9.0% | 0.1% | ||
| Q1 25 | 1.1% | -14.5% | ||
| Q4 24 | 6.5% | 11.2% | ||
| Q3 24 | -9.2% | -15.9% | ||
| Q2 24 | 12.2% | 3.4% | ||
| Q1 24 | 5.5% | -13.3% |
| Q4 25 | 3.7% | 2.4% | ||
| Q3 25 | 4.3% | 3.9% | ||
| Q2 25 | 8.0% | 12.9% | ||
| Q1 25 | 2.8% | 27.0% | ||
| Q4 24 | 3.1% | 18.3% | ||
| Q3 24 | 3.2% | 33.5% | ||
| Q2 24 | 1.3% | 31.8% | ||
| Q1 24 | 2.9% | 27.3% |
| Q4 25 | 0.20× | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | 11.55× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 9.42× | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.54× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TWIN
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
